SYNM and breast cancer: Epigenetic silencing of the Synemin tumor suppressor gene (SYNM) in breast cancer is associated with poorer survival, lymph node involvement and advanced tumor grade [34] MAP2K6 was a member of a four gene-panel used to predict prognosis in bladder cancer [41].